DGAP-News: Nanostart increases shareholding in Singapore medical technology company BioMers
(firmenpresse) - Nanostart AG / Miscellaneous
12.08.2010 06:01
Dissemination of a Corporate News, transmitted by
DGAP - a company of EquityStory AG.
The issuer / publisher is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
- Unique position in multi-billion global market for aesthetic
orthodontic devices
- Sales and marketing to be expanded into all key markets worldwide
- Nanostart ownership increased to about 25 percent
Frankfurt / Singapore - August 12, 2010 - Nanostart AG has increased its
ownership share in Singapore-based BioMers Pte Ltd. The proceeds from this
current round of financing are to be used to expand the company's global
sales network, especially in Europe and the USA. In particular, the company
plans to hire new staff as well as to invest in wide-ranging sales and
marketing activities. A further investment objective is to automate the
company's production, which takes place in its Singapore headquarters.
BioMers produces innovative polymer composite wires based on
nanotechnology. Its first successful commercial application has been in
orthodontic wires used for braces and retainers. Until now, these wires had
to be made of metal in order to have the needed physical properties. With
its revolutionary technology, BioMers is now the world's only company able
to produce these from clear or colored translucent plastic and thus to make
braces and retainers which are aesthetically pleasing. This breakthrough
provides the company with a decisive competitive advantage, giving it the
potential to fundamentally transform the global market for orthodontic
devices. BioMers offers a complete set of products for aesthetic
orthodontic treatment.
'BioMers has a truly unique product portfolio in the field of orthodontics
which fits very well with the current market trend,' remarked Andreas
Kröll, managing director of Singapore-based Nanostart subsidiary Nanostart
Asia Pte Ltd. 'The global market for braces is becoming much more oriented
toward aesthetics, and this market - as well as the return potential for
investors - is enormous.'
Nanostart holds its position in BioMers as lead investor through its
Nanostart Singapore Early Stage Venture Fund. With this transaction, the
fund's shareholding in BioMers rises from 16 to about 25 percent.
About Nanostart:
Nanostart AG, headquartered in the German financial capital of Frankfurt,
is the world's leading nanotechnology investment company, with portfolio
companies spanning the globe from Silicon Valley to Singapore. The company
provides venture capital financing for nanotechnology companies in various
growth phases with a focus on innovation-driven industries of the future
such as cleantech, life sciences and IT/electronics. Through its subsidiary
and venture capital fund in Singapore, Nanostart is proud to be the
investment partner of the Singaporean government. For further information
about the company, please visit www.nanostart.de.
About BioMers:
BioMers Pte Ltd is a spin-off of the world-renowned National University of
Singapore (NUS). Using the company's proprietary technology, originally
developed at NUS, extremely strong nanofiber-reinforced polymer composites
can be produced for various biomedical applications. These first of these
revolutionary innovations to be brought to market are the company's
aesthetic products for orthodontic applications, including translucent
wires for braces and translucent retainers. Further information may be
found at www.biomersbraces.com.
Disclaimer
This notice constitutes neither an offer to sell nor a solicitation of
offers to purchase or subscribe to securities. There will be no public
offering of securities of Nanostart AG in conjunction with the existing
listing of its shares in the 'Entry Standard' segment of the regulated
unofficial market (Freiverkehr) on the Frankfurt Stock Exchange. This
notice does not constitute a securities prospectus. Neither this notice nor
the information contained within is intended for direct or indirect
distribution within the United States of America, Canada, Australia or
Japan.
Nanostart AG
Public Relations
Dr. Hans Joachim Dürr
Goethestrasse 26-28
D-60313 Frankfurt
Germany
phone: +49 (0)69-21 93 96 111
fax: +49 (0)69-21 93 96 122
e-mail: presse(at)nanostart.de
12.08.2010 06:01 Ad hoc announcement, Financial News and Press Release distributed by DGAP. Medienarchiv atwww.dgap-medientreff.deandwww.dgap.de---------------------------------------------------------------------------
Datum: 12.08.2010 - 06:01 Uhr
Sprache: Deutsch
News-ID 31965
Anzahl Zeichen: 0
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 223 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DGAP-News: Nanostart increases shareholding in Singapore medical technology company BioMers"
steht unter der journalistisch-redaktionellen Verantwortung von
Nanostart AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
